EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
about
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinomaPercutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinomaManagement of people with early or very early stage hepatocellular carcinoma: a network meta-analysisManagement of people with intermediate-stage hepatocellular carcinoma: a network meta-analysisYttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinomaExternal beam radiotherapy for unresectable hepatocellular carcinomaRadiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinomaHepatocellular carcinoma in elderly patients: challenges and solutionsImmunobiology of hepatocarcinogenesis: Ways to go or almost there?HVPG signature: A prognostic and predictive tool in hepatocellular carcinomaTherapeutic Strategies in HCC: Radiation ModalitiesAntiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and PrognosisDiagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and DevelopmentsSurveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisManagement of HBV and HBV/HDV-Associated Liver CirrhosisCurrent Treatment Approaches to HCC with a Special Consideration to TransplantationMulti-OMICs and Genome Editing Perspectives on Liver Cancer Signaling NetworksYttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature ReviewUsefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsCurrent status of transarterial radioembolizationAdvanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinomaSurveillance for Hepatocellular Carcinoma in Patients with NASHHepatocellular Carcinoma: Risk Factors, Diagnosis and TreatmentFocal liver lesions found incidentallyNew advances in hepatocellular carcinomaThe Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-AnalysisA concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016Development and novel therapeutics in hepatocellular carcinoma: a reviewQuality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial ChemoembolizationTransarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular CarcinomaThe Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular CarcinomaLaparoscopic and robot-assisted laparoscopic digestive surgery: Present and future directionsCombined locoregional treatment of patients with hepatocellular carcinoma: State of the artRadiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic reviewBrazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinomaComputed Tomography and Ultrasounds for the Follow-up of Hepatocellular Carcinoma Ablation: What You Need to KnowHepatocellular Carcinoma in Pakistan: National Trends and Global PerspectiveCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaImaging of HCC-Current State of the ArtContrast Enhanced MRI in the Diagnosis of HCC
P2860
Q24186130-D030B933-2D88-4C79-909E-2DC5B005A793Q24186496-2D5A3666-C398-4249-82C3-19F655C85320Q24186856-53FBD87D-086D-4AF5-AA6D-7CD3D723CD7FQ24186892-8B0A69CC-F4ED-4296-85FF-188350A3E2AEQ24194017-2D03D0E4-C0DD-456A-B21E-08E53960D7AFQ24194024-C06CD594-95FB-4E4B-92BD-9D5F035CC771Q24201669-583A22EC-FDE0-4A39-9301-F50CA98C48BBQ26738274-9293A46A-06DD-49BD-A548-8F89A849EF0EQ26738293-FBBFE33E-A0F8-4EC1-8E9F-64682F906E9BQ26738597-E63AD305-114A-499F-BFEF-5948F5CFF0C5Q26738658-590523EF-F633-46EE-82BE-6C6DC558A4A2Q26740313-5B6E50DC-6ED9-4124-8E28-D63EDA3973B0Q26740315-9E6CC714-A78A-4CE7-A879-9179221E8696Q26740317-D686D330-7B66-4716-A023-4835AECFFF07Q26740323-82B859EA-5C94-49D1-9ED6-4CD710EE6AB6Q26740375-04D0B7EC-28ED-4A10-84E9-B6064D078545Q26741086-88ED3567-D349-4E99-81A3-E61854954D93Q26743603-BF6BCD4C-CC21-4267-9134-23E9ABC63279Q26743666-5018D80C-6282-4889-9721-6A19272EE5EEQ26744307-810B5473-2083-4DFE-99FD-AAB2A20CB2F2Q26745449-0532461B-C386-487B-9EB6-04F8971B5A47Q26747428-6D247409-125A-428A-950E-719A6D06EDE2Q26747551-8396BE94-039A-41B0-960B-F34BCCAC170BQ26749312-0965A4EF-7E02-4293-ADC6-2F4704FD4320Q26749329-960AA0E3-55A6-4635-A55A-1FED5383A1A1Q26749847-D31EF4A4-790E-420E-A24B-90A7C6BA84D9Q26752478-3DAA1A3D-5CCB-45DB-BF41-13EABF04B0C6Q26752854-29507E99-B070-42A9-9968-357ED26E4A2AQ26753024-843B604F-5291-4672-A013-F67A4B8F4A38Q26753089-8F650E84-BB03-44D0-9733-80B5B3012666Q26764896-78484D97-5136-409C-BDA9-3C8FBA78E367Q26766111-6D0D7F02-6AD6-4197-A556-AB64287A45B5Q26766127-29F29B58-ACA0-43EF-A347-1A85658F9E34Q26766410-7B33B4E3-8AC8-49F6-8016-4D27AC1CCD56Q26766707-4DDA10A1-1FAE-48D0-B165-73EFC5ADF485Q26767189-40182F0F-8B09-483F-BBF2-D6B9CBCB3A75Q26767217-33BE2C24-5A80-4F2F-9C61-83F68A22F98BQ26767346-21839251-A4DC-41BA-84AE-25D64686AECAQ26768463-F6DD7217-A4FD-47F0-89A9-59FD2FE3C1C1Q26768472-C4AF9AEC-5628-42A1-B468-21AD4E7CCE84
P2860
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@ast
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@en
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@nl
type
label
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@ast
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@en
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@nl
prefLabel
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@ast
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@en
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@nl
P3181
P1476
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
@en
P304
P3181
P356
10.1016/J.JHEP.2011.12.001
P577
2012-04-01T00:00:00Z